Morphological and quantitative assessment of mast cells in rheumatoid arthritis associated non-specific interstitial pneumonia and usual interstitial pneumonia

Annals of the Rheumatic Diseases

Volumn 65, Issue 5, 2006, Pages 677-680

  Atkins, S R ^a   Matteson, E L ^a   Myers, J L ^a   Ryu, J H ^a   Bongartz, T ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRYPTASE;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CELL STRUCTURE; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG FUNCTION; MALE; MAST CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; STAINING;

AGED; ARTHRITIS, RHEUMATOID; BIOPSY; CELL COUNT; FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MAST CELLS; MIDDLE AGED; VITAL CAPACITY;

EID: 33646256151     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.043877     Document Type: Article

References (16)

1. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003;62:722-7.
2. Turesson C, Matteson EL, Colby TV, Vuk-Pavlovic Z, Vassallo R, Weyand CM, et al. Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis. Arthritis Rheum 2005;52:73-9.
3. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002;297:1689-92.
4. Tetlow LC, Woolley DE. Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis 1995;54:896-903.
5. Inoue Y, King TE Jr, Barker E, Daniloff E, Newman LS. Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis. Am J Respir Crit Care Med 2002;166:765-73.
6. Walls AF, Bennett AR, Godfrey RC, Holgate ST, Church MK. Mast cell tryptase and histamine concentrations in bronchoalveolar lavage fluid from patients with interstitial lung disease. Clin Sci (Lond) 1991;81:183-8.
7. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatioid arthritis. Arthritis Rheum 1988;31:315-24.
8. Hunt LW, Colby TV, Weiler DA, Sur S, Butterfield JH. Immunofluorescent staining for mast cells in idiopathic pulmonary fibrosis: quantification and evidence for extracellular release of mast cell tryptase. Mayo Clin Proc 1992;67:941-8.
9. Levi-Schaffer F, Dayton ET, Austen KF, Hein A, Caulfield JP, Gravallese PM, et al. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2. J Immunol 1987;139:3431-41.
10. Davidson S, Mansour A, Gallily R, Smolarski M, Rofolovitch M, Ginsburg H. Mast cell differentiation depends on T cells and granule synthesis on fibroblasts. Immunology 1983;48:439-52.
11. Levi-Schaffer F, Austen KF, Caulfield JP, Hein A, Bloes WF, Stevens RL. Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro. J Immunol 1985;135:3454-62.
12. Crystal RG, Fulmer JD, Baum BJ, Bernardo J, Bradley KH, Bruel SD, et al. Cells, collagen and idiopathic pulmonary fibrosis. Lung 1978;155:199-224.
13. Akers IA, Parsons M, Hill MR, Hollenberg MD, Sanjar S, Laurent GJ, et al. Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. Am J Physiol Lung Cell Mol Physiol 2000;278:L193-201.
14. Taipale J, Lohi J, Saarinen J, Kovanen PT, Keski-Oja J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem 1995;270:4689-96.
15. Takai S, Jin D, Sakaguchi M, Katayama S, Muramatsu M, Sakaguchi M, et al. A novel chymase inhibitor, 4-[1-([bis-(4-methyl-phenyl)-methyl]-carbamoyl)3-(2-ethoxy-benzyl)-4-oxo-a zetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters. J Pharmacol Exp Ther 2003;305:17-23.
16. Sakaguchi M, Takai S, Jin D, Okamoto Y, Muramatsu M, Kim S, et al. A specific chymase inhibitor, NK3201, suppresses bleomycin-induced pulmonary fibrosis in hamsters. Eur J Pharmacol 2004;493:173-6.